ACE opens new rooms on Web site to promote germ fighting
WASHINGTON The Alliance for Consumer Education on Wednesday launched four new rooms on its interactive Web site, www.StopGerms.org, and unveiled a 3-dimensional version of StopGerms.org in Second Life, a virtual online community. ACE’s StopGerms.org, is a website aimed at educating consumers on ways they can help keep their families healthy through proper hygiene practices within the home. Included in the new expansion to the popular interactive site are four new rooms: The Garage, Foyer, Study and Living Room.
Consumers can click on objects in each room such as doorknobs, carpets, toothbrushes, or counters to see which germs are hiding or lurking on each item. A second click of the mouse lets consumers know more about each of the germs and educates them on steps they can take to help protect their families from germs and the diseases they cause.
“ACE is helping parents and families understand the threat of exposure to those germs that can cause colds and flu,” stated Joseph Healy, ACE president.
ACE is a nonprofit foundation dedicated to advancing community health and well-being.
Walgreens gives customers direction on cough-cold OTC dosing for children
DEERFIELD, Ill. Walgreens has said that it will advise its customers on the proper, safe use of over-the-counter cough and cold remedies by adding in-store signage to shelves and making its pharmacists available for consultations.
After the announcement from the CHPA Tuesday that cough-cold remedies should not be administered to children under age 4, many cough-cold remedy makers are revising their product labels to reflect the new dosing recommendations before the upcoming cold season. Walgreens has made a commitment to make sure the most current labeled cough and cold remedies will be available during the label-upgrading swap, and newly labeled products will be on shelves as soon as they are available.
The FDA has issued a statement that parents should take precautions when administering cough-cold medicines to children, including, checking active ingredients on the Drug Facts product labeling, avoiding given children two products with the same active ingredients at the same time, following directions, using the appropriate measuring instruments, selecting cough-cold medicines with child-proof caps, recognizing that cough-old remedies do not shorten the length of illness but only treat symptoms, not using cough-cold products for sedation and calling a doctor or pharmacist if any adverse reactions occur after administering.
Better Business Bureau finds that Soft Gel, Option did not misrepresent claims for Clarinol
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Monday determined that Soft Gel Technologies and Optio Health Products Inc. have provided adequate substantiation for claims made in print advertising and on product packaging for Clarinol CLA, a dietary supplement. Claims included:
· “Assists in reducing body fat and maintaining lean muscle tissue for healthy body
· “PureGels Clarinol CLA. For Healthy Body Composition;”
· “Clarinol CLA (Conjugated Linoleic Acid) has been proven in Clarinol-specific clinicals to help attain and sustain proper ratios of fat to lean muscle tissue;”
· “The clinical results show enhanced fat burning, lean muscle retention, and promotion of optimal BMI [Body Mass Index];”
· “PureGels Clarinol CLA in a soft gel is a powerful supplement from natural safflower oil which will help you Reshape Up!”
At the outset, the advertiser explained that Conjugated Linoleic Acid, the active ingredient in Clarinol, is an oil that exists naturally in foods such as dairy and meat products. Clarinol is marketed as a dietary supplement that assists in the reduction of fat mass and increase in lean mass in order to improve body composition.
NAD examined evidence in support of the advertising claims that included one study on the actual product and many on the active ingredient and determined that the studies followed sound methodologies and produced statistically significant results demonstrating a reduction in body fat mass, BMI, waist, waist-to-hip ratio and fat mass around the legs and abdomen, as well as an increase in lean mass.
Following its review of the evidence, NAD determined that the advertiser provided a reasonable basis for the claims at issue.
The company, in its advertiser’s statement, said it “appreciates the opportunity to participate in this proceeding and is pleased with the NAD’s conclusion.”